ABVAX | VIVIX | ABVAX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 26 years | - |
Gain YTD | 21.585 | 19.638 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 469M | 184B | 0% |
Annual Yield % from dividends | 1.03 | 2.37 | 44% |
Returns for 1 year | 29.18 | 31.28 | 93% |
Returns for 3 years | 5.83 | 23.36 | 25% |
Returns for 5 years | 38.12 | 53.42 | 71% |
Returns for 10 years | 50.00 | 114.74 | 44% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AREDX | 28.10 | 0.40 | +1.44% |
American Century Real Estate R6 | |||
PFPPX | 10.30 | 0.14 | +1.38% |
Principal MidCap Growth R3 | |||
LAVRX | 16.31 | 0.12 | +0.74% |
Lord Abbett Fundamental Equity R3 | |||
MGRLX | 4.79 | N/A | N/A |
Morgan Stanley Inst Global Real Est L | |||
FAIDX | 50.45 | -0.29 | -0.57% |
Fidelity Advisor International Discv A |